Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
NCT00559689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2009-03-16
Summary
Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.
Conditions
Interventions
- DRUG
-
Budesonide,hydrofluoroalkane-beclomethasone dipropionate
receive twice-daily administration
- DRUG
-
Budesonide,hydrofluoroalkane-beclomethasone
once-daily administration at bedtime
Sponsors & Collaborators
-
Hamamatsu University
lead OTHER
Principal Investigators
-
Kingo Chida, MD,PhD
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-11-30
- Completion
- 2007-03-31
Countries
- Japan
Study Locations
More Related Trials
-
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
NCT01400906 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
NCT02105012 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
NCT01431950 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma
NCT00504062 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
NCT00522782 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma
NCT00667992 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Steroid Treatment as Regular Therapy in Early Asthma
NCT00641914 ·Status: COMPLETED ·Phase: PHASE4
-
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
NCT01056159 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
NCT02574975 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma
NCT02113436 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
NCT01479621 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of 2 Doses of MAP0010 in Adult Asthmatics
NCT00554970 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients
NCT00453778 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma
NCT00509028 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma
NCT06940700 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?
NCT00509197 ·Status: TERMINATED ·Phase: NA
-
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
NCT01136382 ·Status: COMPLETED ·Phase: PHASE2
-
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide
NCT01219738 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
NCT06502366 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
NCT01436071 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
NCT01159912 ·Status: COMPLETED ·Phase: PHASE3
-
Role of microRNAs in T Cell-Driven Inflammation in Asthma
NCT01484691 ·Status: COMPLETED ·Phase: NA
-
Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in Healthy Participants
NCT05755932 ·Status: COMPLETED ·Phase: PHASE3